Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.33%.

  • AtriCure's EBITDA Margin rose 60800.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.41%, marking a year-over-year increase of 28300.0%. This contributed to the annual value of 9.62% for FY2024, which is 27700.0% down from last year.
  • Latest data reveals that AtriCure reported EBITDA Margin of 0.33% as of Q3 2025, which was up 60800.0% from 3.83% recorded in Q2 2025.
  • In the past 5 years, AtriCure's EBITDA Margin ranged from a high of 137.64% in Q3 2021 and a low of 29.1% during Q1 2021
  • Over the past 5 years, AtriCure's median EBITDA Margin value was 8.07% (recorded in 2023), while the average stood at 3.7%.
  • In the last 5 years, AtriCure's EBITDA Margin surged by 1464000bps in 2021 and then crashed by -1535300bps in 2022.
  • Quarter analysis of 5 years shows AtriCure's EBITDA Margin stood at 19.77% in 2021, then surged by 83bps to 3.38% in 2022, then tumbled by -139bps to 8.07% in 2023, then crashed by -64bps to 13.24% in 2024, then soared by 98bps to 0.33% in 2025.
  • Its EBITDA Margin was 0.33% in Q3 2025, compared to 3.83% in Q2 2025 and 4.81% in Q1 2025.